Positive preclinical results from the three different applications of Xeltis’ restorative small diameter blood vessels have been presented at 2019 International Symposium for Applied Cardiovascular Biology and Vascular Tissue Engineering in Zurich (CH).
All studies showed encouraging patency of the devices, which have been used as carotid artery interposition grafts, arteriovenous shunts and coronary artery bypass grafts (CABG). These results are a positive indication for the potential of Xeltis’ restorative approach in small diameter vessels.
After pioneering its technology in heart valves – currently in clinical phase, Xeltis is now bringing forward new restorative applications in blood vessel replacement.
Small diameter vessels may be used for Coronary Artery Bypass Grafts (CABG) surgeries and in patients with Critical Limb Ischemia (CLI). Today, patients who need small diameters vessel replacements endure invasive vein harvesting, long recovery time and short-lived solutions.
The first edition of the joint symposium of the International Society for Applied Cardiovascular Biology (ISACB) and the International Symposium on Vascular Tissue Engineering (ISVTE) aims to enable successful collaborations from the understanding of cardiovascular pathologies to the development of regenerative approaches.
